private:microphage
|
462082
|
May 29th, 2019 12:00AM
|
MicroPhage, Inc.
|
236
|
4.00
|
Open
|
Biotechnology
|
May 29th, 2019 07:54PM
|
May 29th, 2019 07:54PM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
Open
|
|
Open
|
2400 Trade Centre Ave.,
|
Longmont
|
CO
|
US
|
80503
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 17th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 16th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 15th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 14th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 13th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 12th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 11th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 10th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|
private:microphage
|
462082
|
Feb 9th, 2018 12:00AM
|
MicroPhage, Inc.
|
225
|
5.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
MicroPhage's mission is to be a worldwide leader in bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
|
|
|
|
|
|
|
|
|
|
MicroPhage
|
|
Pharmaceuticals & Biotechnology
|